Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 26 studies | 48% ± 18% | |
| astrocyte | 19 studies | 50% ± 19% | |
| fibroblast | 17 studies | 48% ± 21% | |
| microglial cell | 16 studies | 56% ± 16% | |
| oligodendrocyte | 15 studies | 38% ± 16% | |
| smooth muscle cell | 13 studies | 48% ± 18% | |
| macrophage | 13 studies | 37% ± 16% | |
| oligodendrocyte precursor cell | 13 studies | 42% ± 13% | |
| glutamatergic neuron | 12 studies | 61% ± 23% | |
| pericyte | 12 studies | 50% ± 19% | |
| GABAergic neuron | 11 studies | 58% ± 23% | |
| adipocyte | 10 studies | 70% ± 18% | |
| mast cell | 8 studies | 34% ± 11% | |
| mesothelial cell | 8 studies | 55% ± 24% | |
| endothelial cell of lymphatic vessel | 8 studies | 41% ± 17% | |
| epithelial cell | 7 studies | 50% ± 22% | |
| B cell | 7 studies | 40% ± 13% | |
| basal cell | 7 studies | 52% ± 29% | |
| neuron | 6 studies | 45% ± 21% | |
| T cell | 6 studies | 35% ± 15% | |
| kidney loop of Henle epithelial cell | 5 studies | 47% ± 37% | |
| retinal ganglion cell | 5 studies | 55% ± 27% | |
| cardiac muscle cell | 5 studies | 49% ± 13% | |
| dendritic cell | 5 studies | 35% ± 9% | |
| myeloid cell | 5 studies | 34% ± 10% | |
| ciliated cell | 5 studies | 37% ± 13% | |
| club cell | 5 studies | 54% ± 20% | |
| monocyte | 5 studies | 32% ± 11% | |
| type I pneumocyte | 5 studies | 62% ± 7% | |
| type II pneumocyte | 5 studies | 60% ± 9% | |
| interneuron | 5 studies | 65% ± 26% | |
| cholangiocyte | 4 studies | 67% ± 9% | |
| hepatocyte | 4 studies | 67% ± 24% | |
| glial cell | 4 studies | 34% ± 8% | |
| granule cell | 4 studies | 39% ± 16% | |
| retinal pigment epithelial cell | 4 studies | 67% ± 25% | |
| Mueller cell | 4 studies | 66% ± 19% | |
| amacrine cell | 4 studies | 45% ± 22% | |
| retinal cone cell | 4 studies | 36% ± 11% | |
| retinal rod cell | 4 studies | 48% ± 12% | |
| endothelial cell of vascular tree | 4 studies | 40% ± 15% | |
| muscle cell | 4 studies | 45% ± 20% | |
| abnormal cell | 4 studies | 34% ± 22% | |
| hepatic stellate cell | 3 studies | 51% ± 19% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 47% ± 3% | |
| GABAergic interneuron | 3 studies | 49% ± 19% | |
| progenitor cell | 3 studies | 35% ± 5% | |
| CD4-positive, alpha-beta T cell | 3 studies | 26% ± 2% | |
| vein endothelial cell | 3 studies | 46% ± 17% | |
| GABAergic amacrine cell | 3 studies | 36% ± 15% | |
| OFF-bipolar cell | 3 studies | 39% ± 2% | |
| ON-bipolar cell | 3 studies | 49% ± 11% | |
| glycinergic amacrine cell | 3 studies | 38% ± 10% | |
| retina horizontal cell | 3 studies | 35% ± 9% | |
| neural progenitor cell | 3 studies | 49% ± 25% | |
| ependymal cell | 3 studies | 59% ± 13% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 37% ± 8% | |
| alveolar macrophage | 3 studies | 40% ± 5% | |
| capillary endothelial cell | 3 studies | 41% ± 4% | |
| endothelial cell of artery | 3 studies | 45% ± 10% | |
| myofibroblast cell | 3 studies | 44% ± 19% | |
| natural killer cell | 3 studies | 23% ± 7% | |
| respiratory goblet cell | 3 studies | 53% ± 20% | |
| leukocyte | 3 studies | 57% ± 13% | |
| epithelial cell of proximal tubule | 3 studies | 55% ± 26% | |
| renal principal cell | 3 studies | 71% ± 33% | |
| mucus secreting cell | 3 studies | 46% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 644.70 | 245 / 245 | 100% | 14.59 | 502 / 502 |
| kidney | 100% | 902.65 | 89 / 89 | 100% | 16.34 | 899 / 901 |
| ovary | 100% | 700.37 | 180 / 180 | 100% | 8.72 | 428 / 430 |
| liver | 100% | 356.90 | 226 / 226 | 100% | 12.09 | 404 / 406 |
| thymus | 100% | 780.92 | 653 / 653 | 99% | 15.24 | 601 / 605 |
| breast | 100% | 654.64 | 459 / 459 | 99% | 8.81 | 1110 / 1118 |
| pancreas | 99% | 292.70 | 326 / 328 | 99% | 6.85 | 177 / 178 |
| skin | 100% | 386.61 | 1806 / 1809 | 99% | 14.50 | 466 / 472 |
| brain | 97% | 226.07 | 2572 / 2642 | 100% | 9.32 | 703 / 705 |
| adrenal gland | 100% | 573.89 | 258 / 258 | 97% | 8.04 | 222 / 230 |
| bladder | 100% | 546.52 | 21 / 21 | 96% | 7.48 | 483 / 504 |
| intestine | 100% | 472.53 | 964 / 966 | 96% | 7.93 | 506 / 527 |
| lung | 99% | 346.77 | 574 / 578 | 96% | 6.28 | 1113 / 1155 |
| uterus | 100% | 579.59 | 170 / 170 | 94% | 6.36 | 433 / 459 |
| stomach | 100% | 405.04 | 359 / 359 | 92% | 6.88 | 263 / 286 |
| esophagus | 100% | 479.58 | 1445 / 1445 | 84% | 3.74 | 153 / 183 |
| adipose | 100% | 597.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 734.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.03 | 1 / 1 |
| muscle | 100% | 525.04 | 802 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 242.55 | 240 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 8.70 | 79 / 80 |
| heart | 97% | 277.73 | 837 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 5.41 | 27 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 3.64 | 40 / 45 |
| peripheral blood | 25% | 75.53 | 231 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006465 | Biological process | signal peptide processing |
| GO_0007420 | Biological process | brain development |
| GO_0006974 | Biological process | DNA damage response |
| GO_0061300 | Biological process | cerebellum vasculature development |
| GO_0033108 | Biological process | mitochondrial respiratory chain complex assembly |
| GO_0008015 | Biological process | blood circulation |
| GO_0030728 | Biological process | ovulation |
| GO_0006801 | Biological process | superoxide metabolic process |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0022904 | Biological process | respiratory electron transport chain |
| GO_0001541 | Biological process | ovarian follicle development |
| GO_0006627 | Biological process | protein processing involved in protein targeting to mitochondrion |
| GO_0005743 | Cellular component | mitochondrial inner membrane |
| GO_0042720 | Cellular component | mitochondrial inner membrane peptidase complex |
| GO_0008233 | Molecular function | peptidase activity |
| GO_0004175 | Molecular function | endopeptidase activity |
| GO_0004252 | Molecular function | serine-type endopeptidase activity |
| Gene name | IMMP2L |
| Protein name | Mitochondrial inner membrane protease subunit 2 (IMP2-like protein) Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein) Inner mitochondrial membrane peptidase subunit 2 Mitochondrial inner membrane protease subunit (EC 3.4.21.-) |
| Synonyms | hCG_2039401 tcag7.50 |
| Description | FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . FUNCTION: Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO. . |
| Accessions | ENST00000450877.5 ENST00000405709.7 [Q96T52-1] ENST00000437687.2 Q96T52 ENST00000452895.5 [Q96T52-1] C9JQE1 A0A0C4DG32 ENST00000452753.1 A4D0S9 C9JVB0 ENST00000331762.7 [Q96T52-1] ENST00000447215.5 [Q96T52-2] |